Home Healthcare Medical Devices Intravenous Infusion Pump Market

Intravenous Infusion Pump Market Size, Share & Trends Analysis Report By Product (Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Others), By Disease Indication (Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Intravenous Infusion Pump Market Size & Growth Analysis

The global intravenous infusion pump market size was valued at USD 6.24 billion in 2025 and is projected to grow from USD 6.79 billion in 2026 to USD 13.41 billion by 2034, registering a CAGR of 8.87% during the forecast period from 2026 to 2034. North America dominated the intravenous infusion pump market with a market share of 38.6% in 2025.

An intravenous infusion pump is a medical device designed to deliver fluids, medications, or nutrients directly into a patient’s bloodstream with precise control over rate and volume. Widely used in hospitals, outpatient facilities, and homecare settings, these pumps support applications such as chemotherapy, insulin therapy, pain management, anesthesia, and pediatric care. By enabling accurate, continuous, and controlled drug delivery, infusion pumps enhance treatment effectiveness, reduce human error, and improve patient safety across a wide range of clinical scenarios.

The market is supported by increasing demand for pediatric and neonatal care devices, rising adoption of advanced infusion systems in critical care, and government initiatives promoting patient safety. Opportunities exist in developing countries with expanding healthcare infrastructure, growing homecare services, and integration of automation and connectivity technologies. Moreover, manufacturers are investing in R&D to create innovative solutions for oncology, analgesia, and chronic disease management, enhancing workflow efficiency and improving clinical outcomes globally.

Market Key Takeaways

Global Market Size & Growth

North America held the largest market share, over 50% of the global market.
By Product, the volumetric infusion segment held the highest market share of over 15%.
By Disease Indication, the chemotherapy segment is expected to witness the fastest CAGR of 9.57%.
2025 Market Size
USD 6.24 billion
2034 Projected Market Size
USD 13.38 billion
CAGR (2025-2033)
8.87%
North America
Largest market in 2024
Intravenous Infusion Pump Market Size

Download a Free Sample To learn more about this report.

Product Insights

Volumetric infusion pumps dominate the market due to their high precision in delivering large fluid volumes over extended periods. Widely used in hospitals and critical care units, they ensure accurate medication and fluid administration, reducing the risk of errors. These pumps are compatible with multiple therapy types, including hydration, antibiotics, and parenteral nutrition. Their reliability, ease of use, and integration with hospital systems make them a preferred choice for healthcare providers managing diverse patient populations.

Intravenous Infusion Pump Market Size By Segments

Request Customizationto receive a tailored report.

Disease Indication Insights

The pediatrics and neonatology segment leads the disease indication category, reflecting the critical need for precise and safe medication delivery in infants and young children. These patients require carefully controlled infusion rates to avoid complications, particularly in neonatal intensive care units. Advanced infusion pumps designed for pediatric use provide accurate dosing, minimize errors, and enhance safety, making them indispensable in managing treatments such as nutrition, antibiotics, and pain management for vulnerable patients.

Intravenous Infusion Pump Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America remains the dominant region in the global intravenous infusion pump market due to the presence of advanced healthcare infrastructure, increasing hospital admissions, and a high prevalence of chronic diseases. The region benefits from rapid adoption of technologically advanced infusion systems, such as smart pumps integrated with IoT and AI, and strong regulatory frameworks ensuring device safety. Moreover, leading medical device companies actively invest in R&D to enhance product accuracy, efficiency, and connectivity, further driving the demand for reliable and sophisticated infusion solutions across hospitals, homecare, and critical care settings.

  • The United States intravenous infusion pump market is characterized by high adoption of advanced infusion pumps, particularly volumetric and smart systems. Key players such as ICU Medical, Baxter International, and Becton Dickinson are leading product launches and innovations in AI-enabled and EHR-integrated pumps. Rising cases of diabetes, cardiovascular diseases, and oncology treatments are driving demand for precise medication delivery.
  • Canada’s market is growing steadily, supported by increasing healthcare expenditures and the modernization of hospital facilities. Companies like Smiths Medical, Baxter International, and B. Braun are actively providing volumetric and syringe infusion pumps with advanced safety and monitoring features. Chronic disease prevalence and an aging population contribute to the rising demand for continuous and precise drug administration.
North America Intravenous Infusion Pump Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific: Significantly Growing Region

Asia-Pacific is emerging as a rapidly growing region due to expanding healthcare infrastructure, rising chronic disease prevalence, and increasing hospital admissions. The adoption of advanced infusion systems, including smart pumps with AI and IoT integration, is accelerating in leading healthcare centers. The market is further boosted by the growth of homecare services, increasing disposable incomes, and government initiatives aimed at improving patient safety and clinical outcomes. Investments by global manufacturers and rising awareness among healthcare providers about technologically advanced infusion therapies make Asia-Pacific one of the fastest-growing regions globally.

  • China’s intravenous infusion pump market is growing rapidly, fueled by expanding hospital networks, urban healthcare infrastructure, and rising chronic disease cases. Leading companies such as Mindray, B. Braun, and Baxter provide advanced volumetric and syringe infusion pumps, often integrated with smart monitoring systems. The market is further supported by government policies promoting modern healthcare technology and patient safety.
  • India’s market is expanding due to rising hospital infrastructure, increasing outpatient care, and growing prevalence of chronic and critical illnesses. Companies like B. Braun, Fresenius Kabi, and Mindray offer technologically advanced pumps, including portable, smart, and pediatric-focused devices. Moreover, government initiatives and healthcare modernization projects encourage the adoption of automated infusion systems.

Company Market Share

In the global market, companies are focusing on advancing smart infusion technologies that improve dosing accuracy and patient safety. Efforts are directed toward integrating wireless connectivity, AI-based monitoring, and automated alerts to enhance clinical workflow efficiency. Manufacturers are also developing portable and compact devices suitable for home healthcare, alongside robust software solutions for real-time data tracking. Moreover, there is a strong emphasis on compliance with regulatory standards and designing pumps that reduce medication errors while supporting diverse healthcare settings.

Baxter

Baxter International, established in 1931 in Chicago, is a leading player in the intravenous infusion pump market. The company focuses on developing advanced infusion systems that enhance patient safety and dosing accuracy. Baxter emphasizes smart pump technologies with integrated safety features and connectivity solutions for hospitals and home care. Its ongoing innovations target workflow efficiency, real-time monitoring, and compliance with global regulatory standards, reinforcing its strong presence.

  • In September 2025, Baxter International Inc. introduced the Welch Allyn Connex 360 Vital Signs Monitor, a patient monitoring device designed to enhance clinical workflows and patient care. This next-generation monitor captures a comprehensive set of vital signs—including blood pressure, temperature, pulse rate, respiration rate, and blood oxygen levels—for adult, pediatric, and neonatal patients in under one minute.

List of Key and Emerging Players in Intravenous Infusion Pump Market

Baxter
Braun Medical Inc.
Medtronic
Micrel Medical Devices SA
Boston Scientific Corporation
Cardinal Health
Fresenius Kabi AG
ICU Medical, Inc.
Hoffmann-La Roche Ltd
Tandem Diabetes Care, Inc.
Terumo Corporation
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Moog Inc.
IRadimed Corporation

Key Industry Developments

June 2026
B. Braun expanded its infusion therapy portfolio with advancements in Spaceplus infusion pump systems and digital connectivity solutions. The company focused on improving medication safety, workflow efficiency, and smart hospital integration.
March 2026
Baxter expanded its infusion pump technologies with enhancements to the Novum IQ infusion platform. The solutions support connected medication delivery, interoperability, and improved clinical decision-making in hospitals.
January 2026
Fresenius Kabi expanded its infusion pump portfolio with new digital features and safety-focused technologies. The company continued strengthening its Volumat and Agilia infusion systems for hospitals and healthcare facilities.
October 2025
ICU Medical expanded its Plum 360 infusion system capabilities with software enhancements supporting medication safety and interoperability. The company continued advancing smart infusion solutions for acute care environments.

Report Scope

Segmentation

By Product 8
  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Insulin Infusion Pumps
  • Enteral Infusion Pumps
  • Ambulatory Infusion Pumps
  • Patient-Controlled Analgesia Infusion Pumps
  • Implantable Infusion Pumps
  • Others
By Disease Indication 7
  • Chemotherapy
  • Diabetes
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics/Neonatology
  • Hematology
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Baxter · Braun Medical Inc. · Medtronic · Micrel Medical Devices SA · Boston Scientific Corporation
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The intravenous infusion pump market size is valued at USD 6.79 Billion in 2026 and is projected to reach USD 13.41 Billion by 2034, at a CAGR of 8.87% during the forecast period 2026-2034.

North America dominated the market with a share of 38.6% in 2025.

The leading players in this market are Baxter, Braun Medical Inc., Medtronic, Micrel Medical Devices SA, Boston Scientific Corporation.

The intravenous infusion pump market is projected to grow at a CAGR of 8.87% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: